ABCB1 and acute myeloid leukemia: Our comprehensive survey of the ClinPGx/PharmGKB database revealed a diverse landscape of pharmacogenomic variants in AML and ALL, with the ABCB1 gene exhibiting the highest frequency in both subtypes, highlighting its central role in mediating resistance.